Gastroesophageal reflux: Management guidance for the pediatrician

Pediatrics

Volumn 131, Issue 5, 2013, Pages

  Lightdale, Jenifer R ^a   Gremse, David A ^a   Heitlinger, Leo A ^a   Cabana, Michael ^a   Gilger, Mark A ^a   Gugig, Roberto ^a   Hill, Ivor D ^a  

^a NONE

Author keywords

Barrett esophagus; Diagnostic imaging; Extraesophageal symptoms; Gastroesophageal reflux; Gastroesophageal reflux disease; Gastrointestinal endoscopy; Global consensus; Guidelines; Impedance monitoring; Lifestyle changes; Pediatrics; Proton pump inhibitors; Reflux related disease; Regurgitation; Review; Rumination; Vomiting

Indexed keywords

ANTACID AGENT; BACLOFEN; BETHANECHOL; CIMETIDINE; CISAPRIDE; ERYTHROMYCIN; ESOMEPRAZOLE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METOCLOPRAMIDE; NIZATIDINE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROKINETIC AGENT; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; TECHNETIUM 99M;

AGE DISTRIBUTION; ARTICLE; CHILD; CHILD NUTRITION; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); CONSERVATIVE TREATMENT; CONSTIPATION; CONSULTATION; CONTRAST RADIOGRAPHY; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM EXAMINATION; DIGESTIVE TRACT ENDOSCOPY; DROWSINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; ESOPHAGITIS; ESOPHAGUS BIOPSY; ESOPHAGUS PH; ESOPHAGUS SCINTISCANNING; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYMPTOM; FOOD AND DRUG ADMINISTRATION; GASTROENTEROLOGIST; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL TRACT SCINTISCANNING; HEALTH CARE DELIVERY; HEARTBURN; HIGH RISK POPULATION; HUMAN; INAPPROPRIATE PRESCRIBING; LIFESTYLE MODIFICATION; MEDICAL SOCIETY; MULTIPLE INTRALUMINAL IMPEDANCE; NAUSEA; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT REFERRAL; PATIENT SELECTION; PEDIATRICIAN; PHYSICAL EXAMINATION; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFLUX ESOPHAGITIS; RESTLESSNESS; RISK BENEFIT ANALYSIS; SIDE EFFECT; SMOKING CESSATION; STOMACH FUNDOPLICATION; TACHYPHYLAXIS; TREATMENT INDICATION; UNITED STATES; WEIGHT REDUCTION;

BARRETT ESOPHAGUS; DIAGNOSTIC IMAGING; EXTRAESOPHAGEAL SYMPTOMS; GASTROESOPHAGEAL REFLUX; GASTROESOPHAGEAL REFLUX DISEASE; GASTROINTESTINAL ENDOSCOPY; GLOBAL CONSENSUS; GUIDELINES; IMPEDANCE MONITORING; LIFESTYLE CHANGES; PEDIATRICS; PROTON PUMP INHIBITORS; REFLUX-RELATED DISEASE; REGURGITATION; REVIEW; RUMINATION; VOMITING;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; DIET THERAPY; DISEASE MANAGEMENT; ESOPHAGEAL PH MONITORING; ESOPHAGOSCOPY; FEMALE; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HUMANS; INFANT; MALE; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROTON PUMP INHIBITORS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84877037873     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-0421     Document Type: Article

References (64)

1. Nelson SP, Chen EH, Syniar GM, Christoffel KK; Pediatric Practice Research Group. Prevalence of symptoms of gastroesophageal reflux during childhood: a pediatric practice-based survey. Arch Pediatr Adolesc Med. 2000;154(2):150-154 (Pubitemid 30075195)
2. Campanozzi A, Boccia G, Pensabene L, et al. Prevalence and natural history of gastroesophageal reflux: pediatric prospective survey. Pediatrics. 2009;123(3):779-783
3. Shalaby TM, Orenstein SR. Efficacy of telephone teaching of conservative therapy for infants with symptomatic gastroesophageal reflux referred by pediatricians to pediatric gastroenterologists. J Pediatr. 2003;142(1):57-61 (Pubitemid 36106390)
4. Vandenplas Y, Rudolph CD, Di Lorenzo C, et al North American Society for Pediatric Gastroenterology Hepatology and Nutrition; European Society for Pediatric Gastroenterology Hepatology and Nutrition. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr. 2009;49(4):498-547
5. Sherman PM, Hassall E, Fagundes-Neto U, et al. A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population. Am J Gastroenterol. 2009;104(5):1278-1295, quiz 1296
6. Shay S, Tutuian R, Sifrim D, et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol. 2004;99(6):1037-1043 (Pubitemid 38917805)
7. Rudolph CD, Mazur LJ, Liptak GS, et al North American Society for Pediatric Gastroenterology and Nutrition. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr. 2001;32(suppl 2):S1-S31 (Pubitemid 32606853)
8. Martin AJ, Pratt N, Kennedy JD, et al. Natural history and familial relationships of infant spilling to 9 years of age. Pediatrics. 2002;109(6):1061-1067 (Pubitemid 34587431)
9. Fernandez S, Aspirot A, Kerzner B, Friedlander J, Di Lorenzo C. Do some adolescents with rumination syndrome have "supragastric vomiting"? J Pediatr Gastroenterol Nutr. 2010;50(1):103-105
10. Sheikh S, Goldsmith LJ, Howell L, Hamlyn J, Eid N. Lung function in infants with wheezing and gastroesophageal reflux. Pediatr Pulmonol. 1999;27(4):236-241 (Pubitemid 29190281)
11. Sheikh S, Stephen T, Howell L, Eid N. Gastroesophageal reflux in infants with wheezing. Pediatr Pulmonol. 1999;28(3):181-186 (Pubitemid 29420283)
12. Mastronarde JG, Anthonisen NR, Castro M, et al American Lung Association Asthma Clinical Research Centers. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med. 2009;360(15):1487-1499
13. Kiljander TO, Junghard O, Beckman O, Lind T. Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med. 2010;181(10):1042-1048
14. Littner MR, Leung FW, Ballard ED, II, Huang B, Samra NK Lansoprazole Asthma Study Group. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest. 2005;128(3):1128-1135 (Pubitemid 41324386)
15. Sopo SM, Radzik D, Calvani M. Does treatment with proton pump inhibitors for gastroesophageal reflux disease (GERD) improve asthma symptoms in children with asthma and GERD? A systematic review. J Investig Allergol Clin Immunol. 2009;19(1):1-5
16. Chan WW, Chiou E, Obstein KL, Tignor AS, Whitlock TL. The efficacy of proton pump inhibitors for the treatment of asthma in adults: a meta-analysis. Arch Intern Med. 2011;171(7):620-629
17. DiMango E, Holbrook JT, Simpson E, et al American Lung Association Asthma Clinical Research Centers. Effects of asymptomatic proximal and distal gastroesophageal reflux on asthma severity. Am J Respir Crit Care Med. 2009;180(9):809-816
18. Gibson PG, Henry RL, Coughlan JL. Gastrooesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev. 2003;(2):CD001496
19. Jung HK. Epidemiology of gastroesophageal reflux disease in Asia: a systematic review. J Neurogastroenterol Motil. 2011;17(1):14-27
20. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54(5):710-717 (Pubitemid 40559260)
21. Cameron AJ, Lagergren J, Henriksson C, Nyren O, Locke GR, III, Pedersen NL. Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology. 2002;122(1):55-59 (Pubitemid 34049194)
22. Chak A, Faulx A, Eng C, et al. Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia. Cancer. 2006;107(9):2160-2166 (Pubitemid 44665649)
23. Mohammed I, Cherkas LF, Riley SA, Spector TD, Trudgill NJ. Genetic influences in gastro-oesophageal reflux disease: a twin study. Gut. 2003;52(8):1085-1089 (Pubitemid 36877417)
24. Hassall E. Endoscopy in children with GERD: " the way we were" and the way we should be. Am J Gastroenterol. 2002;97(7):1583-1586 (Pubitemid 34761374)
25. Hassall E, Kerr W, El-Serag HB. Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediatr. 2007;150:262-267, 267. e1
26. Hassall E. Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children. J Pediatr. 2005;146(suppl 3):S3-S12 (Pubitemid 40332489)
27. Orenstein SR, McGowan JD. Efficacy of conservative therapy as taught in the primary care setting for symptoms suggesting infant gastroesophageal reflux. J Pediatr. 2008;152(3):310-314
28. Gupta SK, Hassall E, Chiu YL, Amer F, Heyman MB. Presenting symptoms of nonerosive and erosive esophagitis in pediatric patients. Dig Dis Sci. 2006;51(5):858-863 (Pubitemid 44030803)
29. Salvatore S, Hauser B, Vandemaele K, Novario R, Vandenplas Y. Gastroesophageal reflux disease in infants: how much is predictable with questionnaires, pH-metry, endoscopy and histology? J Pediatr Gastroenterol Nutr. 2005;40(2):210-215 (Pubitemid 40269744)
30. Kleinman L, Revicki DA, Flood E. Validation issues in questionnaires for diagnosis and monitoring of gastroesophageal reflux disease in children. Curr Gastroenterol Rep. 2006;8(3):230-236 (Pubitemid 43862772)
31. Gold BD, Gunasekaran T, Tolia V, et al. Safety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2007;45(5):520-529 (Pubitemid 350307136)
32. Størdal K, Johannesdottir GB, Bentsen BS, Sandvik L. Gastroesophageal reflux disease in children: association between symptoms and pH monitoring. Scand J Gastroenterol. 2005;40(6):636-640 (Pubitemid 40827524)
33. Deal L, Gold BD, Gremse DA, et al. Age-specific questionnaires distinguish GERD symptom frequency and severity in infants and young children: development and initial validation. J Pediatr Gastroenterol Nutr. 2005;41(2):178-185 (Pubitemid 41099365)
34. Rosen R, Lord C, Nurko S. The sensitivity of multichannel intraluminal impedance and the pH probe in the evaluation of gastroesophageal reflux in children. Clin Gastroenterol Hepatol. 2006;4(2):167-172 (Pubitemid 43199686)
35. Rosen R, Nurko S. The importance of multichannel intraluminal impedance in the evaluation of children with persistent respiratory symptoms. Am J Gastroenterol. 2004;99(12):2452-2458 (Pubitemid 40039378)
36. Thakkar K, El-Serag HB, Mattek N, Gilger MA. Complications of pediatric EGD: a 4-year experience in PEDS-CORI. Gastrointest Endosc. 2007;65(2):213-221 (Pubitemid 46157117)
37. Volonaki E, Sebire NJ, Borrelli O, et al. Gastrointestinal endoscopy and mucosal biopsy in the first year of life: indications and outcome. J Pediatr Gastroenterol Nutr. 2012;55(1):62-65
38. Isolauri E, Tahvanainen A, Peltola T, Arvola T. Breast-feeding of allergic infants. J Pediatr. 1999;134(1):27-32 (Pubitemid 29048675)
39. Vance GH, Lewis SA, Grimshaw KE, et al. Exposure of the fetus and infant to hens' egg ovalbumin via the placenta and breast milk in relation to maternal intake of dietary egg. Clin Exp Allergy. 2005;35(10):1318-1326
40. Clarke P, Robinson MJ. Thickening milk feeds may cause necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2004;89(3):F280
41. Bhat RY, Rafferty GF, Hannam S, Greenough A. Acid gastroesophageal reflux in convalescent preterm infants: effect of posture and relationship to apnea. Pediatr Res. 2007;62(5):620-623 (Pubitemid 351339001)
42. Corvaglia L, Rotatori R, Ferlini M, Aceti A, Ancora G, Faldella G. The effect of body positioning on gastroesophageal reflux in premature infants: evaluation by combined impedance and pH monitoring. J Pediatr. 2007;151:591-596, 596.e1
43. Orenstein SR, Whitington PF, Orenstein DM. The infant seat as treatment for gastroesophageal reflux. N Engl J Med. 1983;309(13):760-763 (Pubitemid 13004284)
44. Jung WJ, Yang HJ, Min TK, et al. The efficacy of the upright position on gastroesophageal reflux and reflux-related respiratory symptoms in infants with chronic respiratory symptoms. Allergy Asthma Immunol Res. 2012;4(1):17-23
45. Avidan B, Sonnenberg A, Schnell TG, Sontag SJ. Walking and chewing reduce postprandial acid reflux. Aliment Pharmacol Ther. 2001;15(2):151-155 (Pubitemid 32142490)
46. Moazzez R, Bartlett D, Anggiansah A. The effect of chewing sugar-free gum on gastro-esophageal reflux. J Dent Res. 2005;84(11):1062-1065 (Pubitemid 43828157)
47. Smoak BR, Koufman JA. Effects of gum chewing on pharyngeal and esophageal pH. Ann Otol Rhinol Laryngol. 2001;110(12):1117-1119 (Pubitemid 33140571)
48. Cucchiara S, Staiano A, Romaniello G, Capobianco S, Auricchio S. Antacids and cimetidine treatment for gastro-oesophageal reflux and peptic oesophagitis. Arch Dis Child. 1984;59(9):842-847 (Pubitemid 14037080)
49. Sedman A. Aluminum toxicity in childhood. Pediatr Nephrol. 1992;6(4):383-393
50. Tsou VM, Young RM, Hart MH, Vanderhoof JA. Elevated plasma aluminum levels in normal infants receiving antacids containing aluminum. Pediatrics. 1991;87(2):148-151
51. American Academy of Pediatrics, Committee on Nutrition. Aluminum toxicity in infants and children. Pediatrics. 1996;97(3):413-416
52. Gremse DA. GERD in the pediatric patient: management considerations. MedGenMed. 2004;6(2):13
53. Simeone D, Caria MC, Miele E, Staiano A. Treatment of childhood peptic esophagitis: a double-blind placebo-controlled trial of nizatidine. J Pediatr Gastroenterol Nutr. 1997;25(1):51-55 (Pubitemid 27284285)
54. Barron JJ, Tan H, Spalding J, Bakst AW, Singer J. Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenterol Nutr. 2007;45(4):421-427 (Pubitemid 350307159)
55. Orenstein SR, Hassall E. Infants and proton pump inhibitors: tribulations, no trials. J Pediatr Gastroenterol Nutr. 2007;45(4):395-398 (Pubitemid 350307154)
56. Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr. 2009;154:514-520.e4
57. Moore DJ, Tao BS, Lines DR, Hirte C, Heddle ML, Davidson GP. Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux. J Pediatr. 2003;143(2):219-223 (Pubitemid 37082956)
58. Tolia V, Fitzgerald J, Hassall E, Huang B, Pilmer B, Kane R III. Safety of lansoprazole in the treatment of gastroesophageal reflux disease in children. J Pediatr Gastroenterol Nutr. 2002;35(suppl 4):S300-S307 (Pubitemid 35416900)
59. Canani RB, Cirillo P, Roggero P, et al Working Group on Intestinal Infections of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP). Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics. 2006;117(5). Available at: www.pediatrics.org/cgi/content/full/117/ 5/e817
60. Saiman L, Ludington E, Dawson JD, et al National Epidemiology of Mycoses Study Group. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J. 2001;20(12):1119-1124 (Pubitemid 34016422)
61. Craig WR, Hanlon-Dearman A, Sinclair C, Taback S, Moffatt M. Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years. Cochrane Database Syst Rev. 2004;(4):CD003502
62. Marchant JM, Masters IB, Taylor SM, Cox NC, Seymour GJ, Chang AB. Evaluation and outcome of young children with chronic cough. Chest. 2006;129(5):1132-1141
63. Størdal K, Johannesdottir GB, Bentsen BS, et al. Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease. Arch Dis Child. 2005;90(9):956-960 (Pubitemid 41232350)
64. Chang AB, Connor FL, Petsky HL, et al. An objective study of acid reflux and cough in children using an ambulatory pHmetry-cough logger. Arch Dis Child. 2011;96(5):468-472